Profound Medical 2026 AGM: All director nominees elected; incentive plan approved with 36% against

Profound Medical Corp.

Arthur Rosenthal re-elected with 79.0% for vs 21.0% withheld; lowest support among eight nominees.
Unallocated RSUs/DSUs under LTIP approved: 63.9% for, 36.1% against.
PricewaterhouseCoopers LLP reappointed as auditor with 99.5% for.
Total shares outstanding 36,337,637 as of April 2, 2026 record date.

item 5.07item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.